Company: SUND
Filing Date: 2025-06-30
Form Type: 10-K
Source: 0001641172-25-017143
Chunk: 218

Company: Sundance Strategies, Inc.
Filing Date: 2025-06-30
Form: 10-K
Item: Item 1B
Chunk 218
---
. 300 W., Provo, Utah
    84604. Mr. Burton’s ownership includes 3,229,016 warrants held by Radiant Life, LLC.

    (3)
    
    Smartrade
Consulting, Inc. is held by Summit Trustees PLLC for the beneficial owner, Lam Ping of Hong Kong. The address of Smartrade Consulting,
Inc. is 22G Tower 4, The Metropolis, 8 Mau Yip Road, Tsung Kwan Q, N. T., Hong Kong.

    (4)
    Mr.
    Dickman’s ownership includes 1,994,332 warrants.

37

Securities
Authorized for Issuance under Equity Compensation Plans

The
following table provides information as of March 31, 2025, about our common stock that may be issued upon the exercise of options, warrants
and rights under all of our existing equity compensation plans (including individual arrangements):

    Plan Category 
    Number
                                            of securities to be issued upon exercise of outstanding options, warrants and rights  (a)  
    Weighted-average
                                            exercise price of outstanding options, warrants and rights  (b)  
    Number
                                            of securities remaining available for future issuance under equity compensation plans (excluding
                                            securities reflected in column (a))  (c) 

    Equity compensation plans approved by security holders 
     -  
     -  
     - 

    Equity compensation plans not approved by security holders 
     7,457,107  
    $0.64  
     - 

    Total 
     7,457,107  
    $0.64  
     - 

ITEM
13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTORS INDEPENDENCE

Review
and Approval of Related Person Transactions

Before
engaging in a related person transaction, the transaction is presented to non-interested board members for approval. In considering related
person transactions, the non-interested board members are guided by their fiduciary duty to our stockholders. The Board of Directors
does not have any written or oral policies or procedures regarding the review, approval and ratification of transactions with related
person. Additionally, each of our directors and executive officers are required to annually complete a directors’ and officers’
questionnaire that elicits information about related person transactions. Approval of a related person transaction is provided either
verbally or in